Dr. Goel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Euclid Ave
Cleveland, OH 44195Phone+1 216-444-2200
Education & Training
- All India institute of medical sciencesClass of 2020
Publications & Presentations
PubMed
- Impact of Prior Selinexor Exposure on Outcomes of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Exploratory Analysis.Bruno Almeida Costa, Danai Dima, Tomer Mark, Norah Layla Sadek, Stephen Ijioma
Journal of Clinical Medicine. 2025-02-16 - Ciltacabtagene Autoleucel for the Treatment of Relapsed/Refractory Multiple Myeloma: Efficacy, Safety, and Place in Therapy.Utkarsh Goel, Saurabh Zanwar, Andrew John Cowan, Rahul Banerjee, Jack Khouri
Cancer Management and Research. 2025-01-01 - Retreatment of multiple myeloma with previously refractory drugs.Utkarsh Goel, Charalampos Charalampous, Prashant Kapoor, Moritz Binder, Francis K Buadi
Blood Advances. 2024-12-24
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: